Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-113830
Filing Date
2025-09-09
Accepted
2025-09-09 17:07:47
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 hrtx-20250909.htm S-3 487052
2 EX-5.1 hrtx-ex5_1.htm EX-5.1 17753
3 EX-10.1 hrtx-ex10_1.htm EX-10.1 748188
4 EX-23.1 hrtx-ex23_1.htm EX-23.1 5015
5 EX-FILING FEES hrtx_exfilingfees.htm   iXBRL EX-FILING FEES 85889
6 GRAPHIC img166038578_0.jpg GRAPHIC 56635
7 GRAPHIC img170582792_0.jpg GRAPHIC 12744
  Complete submission text file 0000950170-25-113830.txt   1573629

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT hrtx_exfilingfees_htm.xml XML 9433
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290142 | Film No.: 251303995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)